(Q34768573)

4 August 2017

1 reference

title

New strategies for the prevention and treatment of Helicobacter pylori infection (English)

1 reference

Helicobacter pylori infectious disease

4 August 2017

0 references

1 reference

4

Rino Rappuoli

1 reference

4 August 2017

Paolo Ruggiero

1

1 reference

4 August 2017

Samuele Peppoloni

series ordinal

2

1 reference

4 August 2017

Duccio Berti

series ordinal

3

1 reference

4 August 2017

Giuseppe Del Giudice

series ordinal

5

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Expert Opinion on Investigational Drugs

4 August 2017

published in

1 reference

4 August 2017

volume

11

1 reference

4 August 2017

issue

8

1 reference

4 August 2017

page(s)

1127-1138

1 reference

The non-H pylori helicobacters: their expanding role in gastrointestinal and systemic diseases

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Helicobacter pylori infection in Swedish school children: lack of evidence of child-to-child transmission outside the family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Failure to isolate Helicobacter pylori from stray cats indicates that H. pylori in cats may be an anthroponosis--an animal infection with a human pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Helicobacter pylori infection in rural China: exposure to domestic animals during childhood and adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Age at acquisition of Helicobacter pylori in a pediatric Canadian First Nations population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Serological methods for diagnosis of Helicobacter pylori infection and monitoring of eradication therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

The stool antigen test for detection of Helicobacter pylori after eradication therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Molecular mimicry between Helicobacter pylori and the host

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Gastric MALT lymphoma: from aetiology to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Helicobacter pylori infection and the development of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Helicobacter pylori virulence and genetic geography

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Gastric MALT lymphoma: from concept to cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori Eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori? A cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

A novel therapeutic approach for Helicobacter pylori infection: the bismuth-based triple therapy monocapsule

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Esomeprazole: a review of its use in the management of acid-related disorders in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Yucatec Mayan medicinal plants: evaluation based on indigenous uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Anti-Helicobacter pylori activity of Aristolochia paucinervis Pomel extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Screening of Turkish anti-ulcerogenic folk remedies for anti-Helicobacter pylori activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

In vitro anti-Helicobacter pylori activity of panaxytriol isolated from ginseng

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Highly selective antibacterial activity of novel alkyl quinolone alkaloids from a Chinese herbal medicine, Gosyuyu (Wu-Chu-Yu), against Helicobacter pylori in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

The effects of alcohol consumption upon the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

In vitro anti-Helicobacter pylori activity of irisolidone isolated from the flowers and rhizomes of Pueraria thunbergiana

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Chemistry and function of vegetable polyphenols with high molecular weights

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Hepatoprotective and anti-Helicobacter pylori activities of constituents from Brazilian propolis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Anti-Helicobacter pylori activity of Chinese tea: in vitro study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Antibiotic susceptibility of Helicobacter pylori in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Stable amoxicillin resistance in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Differentiation between reinfection and recrudescence of helicobacter pylori strains using PCR-based restriction fragment length polymorphism analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Effect of physiological concentrations of vitamin C on gastric cancer cells and Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Tobacco smoking increases the risk for gastric adenocarcinoma among Helicobacter pylori-infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Cloning, expression and sequencing of Helicobacter felis urease genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Development of a mouse model of Helicobacter pylori infection that mimics human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

The design of vaccines against Helicobacter pylori and their development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Inverse Graded Relation between Alcohol Consumption and Active Infection with Hellcobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1127

Anti-Helicobacter pylori activity of quinolone alkaloids from Evodiae fructus

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/BPB.22.1141

Identifiers

DOI

10.1517/13543784.11.8.1127

1 reference

4 August 2017

1 reference